This combination inhaler contains Tiotropium 18 mcg, Formoterol Fumarate Dihydrate IP 12 mcg, and Ciclesonide IP 400 mcg, designed for the effective management of chronic obstructive pulmonary disease (COPD) and asthma. Tiotropium is a long-acting anticholinergic (LAMA) that relaxes airway muscles to improve airflow. Formoterol Fumarate is a long-acting beta-2 agonist (LABA) that helps in bronchodilation, reducing shortness of breath and wheezing. Ciclesonide is an inhaled corticosteroid (ICS) that reduces airway inflammation, preventing asthma attacks and improving respiratory function. This combination provides enhanced bronchodilation with anti-inflammatory benefits, making it suitable for patients requiring both maintenance therapy and control of symptoms. The inhaler ensures once-daily convenience with targeted lung delivery.
